TechnipFMC (NYSE:FTI – Get Free Report) had its target price lowered by research analysts at Susquehanna from $90.00 to $85.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a “positive” rating on the oil and gas company’s stock. Susquehanna’s price objective points to a potential upside of 24.56% from the […]

Constellation Brands (NYSE:STZ – Get Free Report) had its target price dropped by investment analysts at JPMorgan Chase & Co. from $169.00 to $165.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 19.08% […]

Albemarle (NYSE:ALB – Get Free Report) had its price objective lowered by equities researchers at Rothschild & Co Redburn from $188.00 to $170.00 in a research note issued on Wednesday,MarketScreener reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. Rothschild & Co Redburn’s target price indicates a potential upside of […]

Celanese (NYSE:CE – Get Free Report) had its price target lowered by analysts at Mizuho from $65.00 to $55.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “neutral” rating on the basic materials company’s stock. Mizuho’s price objective points to a potential upside of 19.67% from the company’s previous close. […]

Barrick Mining (NYSE:B – Get Free Report) (TSE:ABX) had its price target cut by investment analysts at UBS Group from $54.00 to $50.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the gold and copper producer’s stock. UBS Group’s price target suggests a potential upside of 36.19% […]

Sun Communities (NYSE:SUI – Get Free Report) had its target price lowered by investment analysts at Mizuho from $143.00 to $137.00 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Mizuho’s target price points to a potential upside of 13.21% from […]

Weatherford International (NASDAQ:WFRD – Get Free Report) had its target price cut by research analysts at Citigroup from $137.00 to $115.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 39.00% from the stock’s current price. WFRD has been […]

ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) had its target price cut by investment analysts at JonesTrading from $11.00 to $10.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently weighed in […]

McCormick & Company, Incorporated (NYSE:MKC – Get Free Report) had its target price cut by investment analysts at TD Cowen from $64.00 to $60.00 in a report issued on Friday,MarketScreener reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s price target would suggest a potential upside of 18.18% from the stock’s […]

Kura Sushi USA (NASDAQ:KRUS – Get Free Report) had its price target decreased by stock analysts at Citigroup from $78.00 to $64.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Citigroup’s target price indicates a potential upside of 17.64% from the company’s current […]

PepsiCo (NASDAQ:PEP – Get Free Report) had its price objective decreased by analysts at Citigroup from $182.00 to $170.00 in a note issued to investors on Thursday,MarketScreener reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s price objective suggests a potential upside of 19.49% from the company’s current price. A number of […]

Natera (NASDAQ:NTRA – Get Free Report) had its price objective cut by Barclays from $280.00 to $260.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target would suggest a potential upside of 2.41% from the stock’s current price. […]